The landscape of type 2 diabetes management is rapidly evolving, with GLP-1 Receptor Agonists (RAs) now recognized for their profound, multi-system benefits far beyond glycemic control. This session is designed for the busy pharmacist seeking to translate clinical evidence into real-world practice. We will move past the A1C to explore the significant impact of GLP-1 RAs on cardiovascular risk reduction, renal protection, and obesity management. Most importantly, this session will equip you with practical, time-efficient interventions and counselling pearls that can be immediately implemented at the counter. You will leave with the confidence and knowledge to identify appropriate candidates, manage patient therapy effectively, and ensure each person with type 2 diabetes is optimally managed.

Sponsored by Novo Nordisk